GLP-1 agonists: Addressing side effects of weight loss drugs
Meeting Announcement
New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Researchers are shedding light on neural mechanisms underlying the progression of Alzheimer's disease. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
A transformative approach to clean hydrogen production is set to take center stage in an upcoming international webinar that bridges molecular innovation with industrial-scale decarbonization.
The Society for Neuroscience (SfN) is pleased to announce Amazon Web Services (AWS), the Dana Foundation, and Johnson & Johnson as the three Gold Sponsors of Neuroscience 2025, SfN’s annual meeting. All three Gold Sponsors will be recognized and featured regularly before, during, and after Neuroscience 2025.